Avidity Biosciences, a San Diego-based biopharmaceutical company, is expanding its ongoing collaboration with Bristol Myers Squibb to identify new cardiovascular therapies.

The technology may not be cheap, but new research published in The American Journal of Cardiology suggests the investment is well worth it. 

The study also unearthed a correlation between such changes and symptom-specific brain networks related to impaired cognition, sense of smell and fatigue. 

After completing primary radiation therapy, patients in remission from cancers of the head and neck are better served by expectant management than routine imaging.

After experiencing firsthand the burdens and rewards of caring for a sick loved one, an academic radiologist underwent an awakening of awareness.

GLP-1 agonists are often taken as daily or weekly injections. A new delivery system could help make it so those same drugs are only required three times per year. 

While TAVR and SAVR are reliable treatments for calcific aortic stenosis, some patients are not considered for those procedures due to severe comorbidities or a limited life expectancy. This is where the investigational Valvosoft device from Cardiawave enters the equation.

Medtronic acquired the technology behind the new device back in August.